Clinical trial NCT00696241 - References

Hypertension — Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension

Citation(s)

•   Bakris GL, Sica D, Weber M, White WB, Roberts A, Perez A, Cao C, Kupfer S
  The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. J Clin Hypertens (Greenwich). 2011 Feb;13(2):81-8. doi: 10.1111/j.1751-7176.
•   White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S
  Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hyperte

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension

Details for clinical trial NCT00696241